DXCM
Dexcom Inc
MEDICAL DEVICES · HEALTHCARE
DexCom, Inc. is a prominent leader in diabetes management, renowned for its state-of-the-art continuous glucose monitoring (CGM) systems that empower patients to optimize their glucose levels effectively. Based in San Diego, California, with a manufacturing facility in Mesa, Arizona, the company is ...
$82.29
+2.95% (+$2.36)
Volume
8.64M
52W High
$92.59
52W Low
$54.11
Market Cap
$29.80B
Next Earnings Report
Last Reported
Oct 29, 2026 Beat
Actual: $0.73
vs. Consensus: $0.66
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q3 2026
Oct 29, 2026
1-Day:
+2.95%
Q2 2026
Jul 30, 2026
1-Day:
+11.95%
5-Day:
+16.64%
Q2 2026
Jul 29, 2026
1-Day:
-0.80%
5-Day:
+16.20%
Q1 2026
Apr 30, 2026
1-Day:
+3.02%
5-Day:
-0.12%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q3'26 | $1.34B | +11.2% | 64.3% | 24.3% | $275.1M |
| Q2'26 | $1.31B | +13.1% | 63.4% | 24.3% | $249.1M |
| Q1'26 | $1.19B | +15.1% | 63.0% | 21.4% | $199.5M |
| Q4'25 | $1.26B | +13.1% | 62.9% | 25.6% | $267.3M |
| Q3'25 | $1.21B | +21.6% | 60.5% | 20.1% | $283.8M |
| Q2'25 | $1.16B | +15.2% | 59.5% | 18.4% | $179.8M |
| Q1'25 | $1.04B | +12.5% | 56.9% | 12.9% | $105.4M |
| Q4'24 | $1.11B | +7.6% | 58.9% | 17.0% | $151.7M |
Company Information
Symbol
DXCM
Company
Dexcom Inc
Market Cap
$29.80B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in MEDICAL DEVICES
Compare DXCM with competitors
Side-by-side earnings comparison